Liminal Biosciences Inc (LMNL)

6.77 -0.18 (-2.59%) USD  |  NASDAQ  |  Jun 02, 16:00
6.90 +0.13 (+1.92%) After-Hours: 20:00
More

Liminal Biosciences News

News

Headline
Wire
Time (ET)
Liminal BioSciences Provides R&D Update
PR Newswire
06/02 08:00
Liminal BioSciences Reports First Quarter Financial Results 2023
PR Newswire
05/09 16:05
The Special Committee of the Board of Directors of Liminal Biosciences Retains an Independent Financial Advisor in Response to Unsolicited Non-Binding Transaction Proposal
PR Newswire
05/08 08:00
Sector Update: Healthcare Stocks Rising Late Afternoon
MT Newswires
04/05 16:11
Sector Update: Health Care Stocks Advancing in Afternoon Trading
MT Newswires
04/05 14:22
Top Midday Gainers
MT Newswires
04/05 13:30
Liminal BioSciences Shares Soar on Structured Alpha Takeover Bid
MT Newswires
04/05 12:06
Liminal, InflaRx top healthcare gainers; Bullfrog, First Wave among losers
SA Breaking News
04/05 10:07
Liminal Biosciences Confirms Receipt of Unsolicited Non-Binding Transaction Proposal
PR Newswire
04/05 07:44
THOMVEST SUBMITS PROPOSAL TO ACQUIRE LIMINAL BIOSCIENCES ON AN ALL CASH BASIS
PR Newswire
04/05 07:30
Liminal BioSciences Reports Fourth Quarter and Year Ended 2022 Financial Results
PR Newswire
03/15 16:05
Liminal BioSciences to Report Fourth Quarter and Year Ended 2022 Financial Results on March 15, 2023
PR Newswire
03/13 16:05
Liminal BioSciences regains Nasdaq compliance
SA Breaking News
02/16 05:03
Liminal BioSciences Regains Compliance with NASDAQ Minimum Bid Price Requirement
PR Newswire
02/15 16:05
Liminal BioSciences Says Reverse Stock Split to Become Effective Feb.1
MT Newswires
01/26 17:38
Liminal BioSciences announces 10-for-1 reverse stock split
SA Breaking News
01/26 16:27
Liminal BioSciences Announces Reverse Stock Split
PR Newswire
01/26 16:05
Liminal BioSciences Announces Priorities For 2023
PR Newswire
01/06 16:05
Liminal BioSciences Announces Holding of Special Meeting of Shareholders
PR Newswire
11/25 08:00
Liminal BioSciences Reports Third Quarter 2022 Financial Results and Business Highlights
PR Newswire
11/09 16:05
Liminal BioSciences to Report Third Quarter 2022 Financial Results on November 9, 2022
PR Newswire
11/08 07:00
Liminal BioSciences Announces Listing Transfer to Nasdaq Capital Market
PR Newswire
09/01 16:15
Liminal Biosciences to Present at H.C. Wainwright 24th Annual Global Investment Conference
PR Newswire
08/29 07:05
Liminal BioSciences Terminates Legacy Contract of Former Plasma-Derived Therapeutics Business
MT Newswires
08/25 09:24
Liminal BioSciences Announces Termination of Legacy CDMO Contract
PR Newswire
08/25 07:05
Liminal BioSciences Reports Second Quarter 2022 Financial Results and Business Highlights
PR Newswire
08/09 17:07
Sector Update: Health Care Stocks Extend Afternoon Retreat
MT Newswires
07/22 15:54
Liminal BioSciences Drops Development of Fezagepras
MT Newswires
07/22 04:45
Liminal BioSciences discontinues fezagepras development
SA Breaking News
07/21 17:34
Liminal BioSciences Announces Discontinuation of Fezagepras Development
PR Newswire
07/21 17:27
Liminal BioSciences Says First Patient Dosed in Phase 1a Clinical Study of Proposed Nitrogen Scavenger Therapy
MT Newswires
05/23 10:04
Liminal BioSciences Announces First Subject Dosed in Phase 1a Single Ascending Dose Clinical Trial of Fezagepras
PR Newswire
05/23 08:00
Liminal BioSciences Reports First Quarter 2022 Financial Results and Business Highlights
PR Newswire
05/10 16:30
Liminal Biosciences to Present at Upcoming Investor Conferences
PR Newswire
05/09 08:30
Liminal BioSciences reports FY results
SA Breaking News
03/18 03:31
Liminal BioSciences Reports Fourth Quarter and Year End 2021 Financial Results
PR Newswire
03/17 18:48
Liminal BioSciences plans additional Phase 1 trial for lead asset next quarter
SA Breaking News
03/14 09:03
Liminal BioSciences Provides Update on Its Lead Drug Candidate Fezagepras
PR Newswire
03/14 08:00
Liminal BioSciences gets Nasdaq notice on minimum bid price deficiency
SA Breaking News
03/07 17:10
Liminal BioSciences Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
PR Newswire
03/07 16:59
Liminal BioSciences repays $39.1M debt to Structured Alpha
SA Breaking News
02/16 07:35
Liminal BioSciences Repays its Secured Debt Ending its Creditor Relationship with Structured Alpha LP
PR Newswire
02/16 07:15
Ocugen Plans to Acquire Liminal BioSciences' Ontario Manufacturing Facility for Undisclosed Sum
MT Newswires
01/27 10:29
Liminal BioSciences Announces Strategic Priorities For 2022
PR Newswire
01/19 16:05
Liminal BioSciences Announces Closing of Sale of Priority Review Voucher
PR Newswire
09/28 16:10
Liminal BioSciences Reports Second Quarter 2021 Financial Results
PR Newswire
08/16 16:05
LMNL, SONO, JRJC and WDC among after hours movers
SA Breaking News
08/13 17:40
Fulcrum Therapeutics, Allied Healthcare Products leads healthcare gainers; SmileDirectClub, EyeGate Pharmaceuticals among major losers
SA Breaking News
08/10 11:02
Top Midday Gainers
MT Newswires
08/09 13:35
WPG, NCTY, ANY among mid-day movers
SA Breaking News
08/09 12:38
Liminal BioSciences Subsidiary to Sell US FDA Priority Review Voucher for $105 Million; Shares Soar
MT Newswires
08/09 10:36
Thinking about buying stock in Golden Nugget Online Gaming, Dare Bioscience, Liminal BioSciences, Windtree Therapeutics, or Daseke Inc?
PR Newswire
08/09 09:31
NVTA, SOS and HVBT among pre market gainers
SA Breaking News
08/09 08:52
Liminal BioSciences Announces Sale of Priority Review Voucher for USD105M
PR Newswire
08/09 07:30
Liminal Biosciences closes sale of plasma-derived therapeutics manufacturing facility
SA Breaking News
07/09 16:18
Skepticism over AmeriSource acquisition speculation, GSK upgraded following investor update, and more in analyst action
SA Breaking News
06/24 10:00
Liminal BioSciences Says Italy's Kedrion Exercised Option to Buy Rest of Plasma Business for $5 Million
MT Newswires
06/23 11:50
Liminal BioSciences Announces Signature of a Share Purchase Agreement for sale of Remaining Plasma-derived Business with Kedrion
PR Newswire
06/23 08:30
Ra Medical Systems, Liminal BioSciences leads healthcare gainers; Cabaletta Bio, MacroGenics among major new losers
SA Breaking News
06/07 11:02
Hot Stocks: M&A, FDA approval, and the next AMC?
SA Breaking News
06/07 09:04
Thinking about buying stock in BioNano Genomics, RA Medical Systems, Microvision, Liminal BioSciences, or Clover Health?
PR Newswire
06/07 08:31
BNGO, CLNE, MVIS and CLOV among notable premarket gainers
SA Breaking News
06/07 08:23
Liminal Announces Voting Results of Its 2021 Annual and Special General Meeting of Shareholders (AGM)
PR Newswire
06/04 16:27
Liminal BioSciences Wins US FDA Ok of its BLA for Ryplazim for Rare Genetic Disorder
MT Newswires
06/04 16:05
FDA grants approval to Liminal BioSciences' Ryplazim treatment
SA Breaking News
06/04 15:42
Liminal BioSciences Announces FDA Approval for its Biologics License Application for Ryplazim® (plasminogen, human-tvmh)
PR Newswire
06/04 15:30
Liminal BioSciences downgraded at Piper Sandler on pipeline update
SA Breaking News
06/02 14:29
--Piper Sandler Downgrades Liminal BioSciences to Neutral From Overweight, Adjusts Price Target to $4.50 From $22
MT Newswires
06/02 06:58
OLED, FUTU, LAKE and BLI among after-hours movers
SA Breaking News
05/28 17:48
Liminal BioSciences Not Moving Fezagepras to Advanced Levels for Idiopathic Pulmonary Fibrosis, Hypertriglyceridemia
MT Newswires
05/28 16:50
Liminal shares slide after plans to stop fezagepras development
SA Breaking News
05/28 16:36
Liminal BioSciences Provides an Update on Currently Planned Clinical Activities for Fezagepras
PR Newswire
05/28 16:30
Liminal Biosciences closes divestiture of plasma collection centers
SA Breaking News
05/21 16:50
Liminal BioSciences Announces Closing of Divestiture of Plasma Collection Centers and Enters into Option Agreement with Kedrion
PR Newswire
05/21 16:45
Liminal BioSciences reports Q1 results
SA Breaking News
05/17 16:46
Liminal BioSciences Reports First Quarter 2021 Financial Results
PR Newswire
05/17 16:30
Liminal BioSciences to Sell Plasma Collection Centers to Kedrion for $17 Million
MT Newswires
05/17 11:10
Liminal enters into agreement with Kedrion to divest plasma collection business
SA Breaking News
05/17 08:42
Liminal BioSciences Enters into Agreement with Kedrion to Divest Its Plasma Collection and Plasma-Derived Therapeutics Business
PR Newswire
05/17 08:30
Liminal BioSciences beats on revenue
SA Breaking News
03/24 16:52
Liminal BioSciences Reports Fourth Quarter and Year End 2020 Financial Results
PR Newswire
03/24 16:39
Study finds no benefit of convalescent plasma as COVID-19 treatment
SA Breaking News
03/10 11:33
NIH halts a convalescent plasma trial in patients with mild COVID-19
SA Breaking News
03/02 13:08
--Analyst Actions: HC Wainwright Starts Liminal BioSciences at Buy with $11 Price Target
MT Newswires
02/18 08:15
Thinking about buying stock in Mesa Air Group, Aphria, Energous Corp, Liminal BioSciences, or Kintara Therapeutics?
PR Newswire
02/10 09:31
APHA, TLRY, SNDL and OGI among premarket gainers
SA Breaking News
02/10 08:23
Liminal BioSciences Plans to Divest Therapeutics Business
MT Newswires
01/28 17:55
Liminal announces strategic alternative plans for plasma-derived therapeutics business
SA Breaking News
01/28 15:13
Liminal BioSciences at 52-Week Lows in Nasdaq, Down 1.5% in Frankfurt Over Therapeutics Business Update
MT Newswires
01/28 07:00
Liminal BioSciences Provides Update on Business Strategy and Focus on Small Molecule Therapeutics
PR Newswire
01/27 18:00
Close Update: Stocks End Slightly Higher Ahead of Earnings Season, Investors Tune in to Developments in Washington
MT Newswires
01/12 16:55
Sector Update: Health Care Stocks Decline Tuesday But Make Up Ground This Afternoon
MT Newswires
01/12 16:02
Sector Update: Health Care Stocks Weighing on Afternoon Trading
MT Newswires
01/12 13:45
Liminal Biosciences subsidiary receives FDA nod for US-based plasma collection centre
SA Breaking News
01/12 10:19
FDA Approves Liminal BioSciences' Plasma Collection Center in Amherst, N.Y.
MT Newswires
01/12 09:36
Liminal BioSciences Receives FDA Approval for its US-based Plasma Collection Center
PR Newswire
01/12 09:00
EyeGate Pharmaceuticals, Editas Medicine leads healthcare gainers; Scopus BioPharma, uniQure among major losers
SA Breaking News
12/21 11:03
--Analyst Actions: Piper Sandler Starts Liminal BioSciences at Overweight With $22 Price Target
MT Newswires
12/21 08:16
Liminal BioSciences Doses First Subject in Study of Anti-Inflammatory Molecule Fezagepras
MT Newswires
12/15 11:07
Dosing underway in Liminal BioSciences' early-stage study of fezagepras
SA Breaking News
12/15 10:26
Liminal BioSciences Announces First Subject Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of Fezagepras
PR Newswire
12/15 09:20
Liminal BioSciences Presents Two Case Histories on Investigational Intravenous Plasminogen (Human) Replacement Therapy at 62nd American Society of Hematology Annual Meeting and Exposition
PR Newswire
12/07 16:05
BLNK, AYRO, KNDI and NNDM among midday movers
SA Breaking News
11/20 12:40
Titan Pharmaceuticals, Idera Pharmaceuticals leads healthcare gainers; AVROBIO, Stealth BioTherapeutics among losers
SA Breaking News
11/20 10:52
BA, BNTX, MFGP and TTM among premarket gainers
SA Breaking News
11/18 08:25
Liminal Biosciences to Present at The Stifel Virtual Healthcare Conference
PR Newswire
11/13 09:20
LI, AMWL, FTCH and REV among after-hours movers
SA Breaking News
11/12 17:43
Liminal BioSciences beats on revenue
SA Breaking News
11/12 17:03
Liminal BioSciences Reports Third Quarter Financial Results
PR Newswire
11/12 16:57
Liminal Biosciences to Reschedule Reporting of Q3 2020 Results and Conference Call
PR Newswire
11/10 18:33
FDA extends review period for Liminal Bio's Ryplazim application
SA Breaking News
11/08 23:49
Liminal BioSciences Announces FDA Extension of Review Period for Ryplazim®(plasminogen) BLA
PR Newswire
11/08 19:01
Liminal Biosciences To Report Q3 2020 Results And Hold Conference Call
PR Newswire
11/06 09:26
Liminal BioSciences Announces Upcoming Presentations for Ryplazim® (plasminogen) at the 62nd ASH Annual Meeting and Exposition
PR Newswire
11/05 04:35
Liminal BioSciences secures equity funding of $30M
SA Breaking News
10/30 08:45
Liminal BioSciences Announces Private Placement Financing of USD$30 Million
PR Newswire
10/30 08:30
FDA Confirms Liminal BioSciences' Refiling of Ryplazim Complete
MT Newswires
09/21 11:28
Liminal BioSciences Provides Update on Progress on BLA for Ryplazim®(plasminogen)
PR Newswire
09/21 08:16
Liminal BioSciences to Present at The H.C. Wainwright 22nd Annual Global Investment Conference
PR Newswire
09/09 08:00
Liminal BioSciences Resubmits BLA to US FDA for Ryplazim for Congenital Plasminogen Deficiency
MT Newswires
09/08 07:49
Liminal Bio refiles U.S. Ryplazim application
SA Breaking News
09/08 06:16
Liminal BioSciences Announces Resubmission of Biologics License Application to U.S. Food and Drug Administration for Ryplazim® (plasminogen) for Treatment of Congenital Plasminogen Deficiency
PR Newswire
09/08 06:00
Liminal BioSciences Announces New Appointments to its Board of Directors
PR Newswire
09/01 08:36
SWBI, ONVO, YRCW and PTI among midday movers
SA Breaking News
08/25 12:47
iBio and Viveve Medical among healthcare gainers; Proteostasis Therapeutics among losers
SA Breaking News
08/25 11:06
PHAS, ORTX, PWR and VAR among after-hours movers
SA Breaking News
08/24 17:46
IBIO, SHLL, SRNE and NAK among midday movers
SA Breaking News
08/24 12:45
Thinking about buying stock in ADMA Biologics, Aldeyra Therapeutics Inc, Cancer Genetics Inc, Borqs Technologies, or Liminal BioSciences?
PR Newswire
08/24 11:45
Healthcare - Top 5 Gainers / Losers
SA Breaking News
08/24 11:08
RIG, RKT among premarket gainers
SA Breaking News
08/24 08:24
Convalescent plasma players rally on FDA emergency use nod
SA Breaking News
08/24 06:22
Liminal BioSciences Registers with SEC for Shelf Offering of 20.2 Million Common Shares by Certain Holders
MT Newswires
08/14 06:22
Liminal Biosciences Narrows Q2 Net Loss, Revenue Slips
MT Newswires
08/11 04:33
Liminal BioSciences reports Q2 results
SA Breaking News
08/10 17:56
Liminal BioSciences reports financial results for Q2-2020
PR Newswire
08/10 17:01
Liminal Biosciences to Present at Canaccord 40th Annual Growth Conference
PR Newswire
08/06 17:01
Alterity Therapeutics leads healthcare gainers; Mallinckrodt among losers
SA Breaking News
08/04 11:04
YRCW, DAC, PACB and SPCE among after-hours movers
SA Breaking News
08/03 17:49
CymaBay Therapeutics leads healthcare gainers; Achieve Life Sciences among losers
SA Breaking News
08/03 11:01
PINS, ZN, KNDI and KODK among midday movers
SA Breaking News
07/31 12:44
Sonnet BioTherapeutics leads healthcare gainers; ThermoGenesis and Edesa Biotech among losers
SA Breaking News
07/31 11:05
TAOP, KODK among premarket losers
SA Breaking News
07/31 08:16
Liminal Biosciences to voluntarily delist from TSX
SA Breaking News
07/22 11:18
Liminal BioSciences Edges Higher in Premarket Trading as It Delists from the Toronto Stock Exchange
MT Newswires
07/22 08:22
Liminal BioSciences to Voluntarily Delist from the Toronto Stock Exchange
PR Newswire
07/22 07:55
Liminal BioSciences acquires Fairhaven Pharmaceuticals in all-stock deal
SA Breaking News
07/17 10:19
Liminal BioSciences Broadens R&D Pipeline With Novel Preclinical Program For Eosinophilic-Driven Diseases
PR Newswire
07/17 08:00
PSXP, KNDI, GNUS and SOLO among midday movers
SA Breaking News
07/06 12:45
Livongo Health and Trevena among healthcare gainers; ObsEva among losers
SA Breaking News
07/06 11:03
NUS, CPST, SOLO and MEIP among midday movers
SA Breaking News
07/02 12:42
Liminal BioSciences Joins CoVIg Plasma Alliance to Contribute to Development of Potential New COVID-19 Therapy
PR Newswire
07/02 11:16
BioLife Solutions leads healthcare gainers; MEI Pharma and Alterity Therapeutics among losers
SA Breaking News
07/02 11:02
NUS, FRAN, DSS and IO among after-hours movers
SA Breaking News
07/01 17:57
Close Update: Stocks End Mixed Amid Vaccine Hopes, Positive US Manufacturing Data; Investors Digest Fed Minutes
MT Newswires
07/01 17:03
Liminal BioSciences up big on start of convalescent plasma collection
SA Breaking News
07/01 15:25
Midday Report: Wall Street Climbs Amid Vaccine Hopes, Recovery Signs
MT Newswires
07/01 13:00
TTOO, MMLP, INO and BLNK among midday movers
SA Breaking News
07/01 12:43
Liminal BioSciences soars on upcoming catalysts for 2020
SA Breaking News
07/01 12:31
Liminal BioSciences Provides Update on 2020 Clinical Development Milestones
MT Newswires
07/01 05:30
Liminal BioSciences Commences Collection of Convalescent Plasma from COVID-19 Recovered Donors
PR Newswire
06/30 17:31
Liminal BioSciences to Present at Raymond James Human Health Innovation Conference
PR Newswire
06/11 17:00
Liminal Announces Voting Results of Its 2020 Annual And Special General Meeting Of Shareholders (AGM)
PR Newswire
06/09 15:53
Liminal BioSciences to present at Jefferies Virtual Healthcare Conference
PR Newswire
05/28 17:30
Liminal BioSciences reports Q1 results
SA Breaking News
05/13 17:16
Progyny among healthcare gainers; Varex Imaging and Capricor Therapeutics among losers
SA Breaking News
05/13 11:02
MediciNova leads healthcare gainers; BioLineRx and Vir Biotechnology among losers
SA Breaking News
04/08 11:04
Liminal BioSciences comments on Coronavirus (COVID-19)
PR Newswire
03/22 15:23
Liminal BioSciences reports Q4 results
SA Breaking News
03/20 17:26
Liminal Biosciences Reports Fourth Quarter and 2019 Year End Results
PR Newswire
03/20 17:01
Liminal BioSciences to report its fourth quarter and year-end 2019 financial results and hold conference call/webcast
PR Newswire
03/20 17:00
Liminal BioSciences Announces Scientific Presentations at Upcoming Keystone Symposia
PR Newswire
02/12 07:30
Liminal BioSciences Outlines Corporate Priorities for 2020
PR Newswire
01/13 07:00
Liminal BioSciences Comments on Unusual Market Activity
PR Newswire
12/23 15:43
Liminal BioSciences Cleared of Any Refinancing Violations by Canadian Financial Regulator
MT Newswires
11/29 06:01
AMF Concludes its Review of the Refinancing Transactions Completed by Liminal BioSciences in April 2019
PR Newswire
11/28 16:40
Liminal BioSciences to Present at Piper Jaffray Healthcare Conference
PR Newswire
11/27 07:30
Liminal BioSciences announces closing of divestiture of bioseparations division to KKR
PR Newswire
11/25 12:03
Liminal Presents New Preclinical Data on PBI-4050 and its Effect on Angio-Proliferative Pulmonary Arterial Hypertension
PR Newswire
11/18 20:05
Liminal BioSciences to Present at the Jefferies 2019 London Healthcare Conference
PR Newswire
11/18 18:00
Liminal BioSciences to Present at Stifel Healthcare Conference
PR Newswire
11/15 18:30
Liminal BioSciences to Commence Trading Common Shares on NASDAQ
PR Newswire
11/15 07:30
Liminal Biosciences Announces Key Appointment to its Leadership Team
PR Newswire
11/13 07:30
Liminal BioSciences Presents New Preclinical Data on PBI-4050 and NASH Candidate PBI-4547
PR Newswire
11/12 19:10
Liminal BioSciences to Report Q3 2019 Results and Hold Conference Call
PR Newswire
11/11 18:16
Liminal BioSciences reports Q3 results
SA Breaking News
11/11 18:14
/C O R R E C T I O N from Source -- Liminal BioSciences Inc./
PR Newswire
11/11 18:10
Liminal Biosciences Presents New Preclinical Data at ASN Kidney Week 2019
PR Newswire
11/11 07:30
Liminal BioSciences to Divest Bioseparations Division to KKR
PR Newswire
11/04 07:00
Liminal BioSciences announces upcoming presentations new data on pulmonary arterial hypertension at the 2019 AHA meeting
PR Newswire
10/29 08:00
Liminal BioSciences announces upcoming presentations at The Liver Meeting 2019
PR Newswire
10/25 08:00
Liminal BioSciences Announces Upcoming Presentations at ASN Kidney Week 2019
PR Newswire
10/24 08:00
Liminal BioSciences to Present At H.C. Wainwright & Co. 3rd Annual NASH Investor Conference
PR Newswire
10/18 18:00
Prometic Shareholders Approve Name Change to Liminal BioSciences Inc.
PR Newswire
10/03 10:56
Prometic Reports First Subject Dosed in Phase I Clinical Study with Single Ascending Doses of PBI-4547
PR Newswire
09/09 08:00
Prometic Life Sciences to Present at H.C. Wainwright & Co. 21st Annual Global Investment Conference
PR Newswire
09/04 08:00
Prometic Life Sciences Announces Intention to Change Name to Liminal BioSciences Inc.
PR Newswire
09/03 18:53
ProMetic Life Sciences reports Q2 results
SA Breaking News
08/12 23:33
Prometic Announces Share Consolidation
PR Newswire
07/02 08:30
Prometic Announces Voting Results of its 2019 AGM
PR Newswire
06/19 18:58
Prometic announces completion of equity rights offering
PR Newswire
06/17 08:30
Prometic Presents New Data on PBI-4050 and its Mechanism of Action on Kidney Fibrosis at the 56th ERA/EDTA Congress
PR Newswire
06/14 03:30
Prometic Life Sciences to Present at Two Upcoming June Investor Conferences
PR Newswire
05/30 09:00
Prometic presents new PBI-4050 and Ryplazim™ (plasminogen) data on lung fibrosis at the 2019 ATS Conference
PR Newswire
05/22 08:30
Prometic sets terms for rights offering; shares down 11%
SA Breaking News
05/15 15:33
Prometic announces terms of equity rights offering
PR Newswire
05/15 15:08
ProMetic Life Sciences reports Q1 results
SA Breaking News
05/09 00:20
Prometic reports its 2019 first quarter financial results
PR Newswire
05/08 19:46
Prometic strengthens its leadership with a new management structure and the appointment of three new directors
PR Newswire
05/08 18:31
Prometic closes $56M capital raise
SA Breaking News
04/23 12:54
Prometic Completes Refinancing Transactions Including C$75 Million (approximately US$56 Million) in Gross Proceeds from New Equity Financing
PR Newswire
04/23 12:33
Prometic Announces Refinancing Transactions
PR Newswire
04/15 07:00
ProMetic Life Sciences reports Q4 results
SA Breaking News
04/02 02:49
Prometic reports fourth quarter and 2018 year-end financial results
PR Newswire
04/01 18:20
Prometic to Report its Fourth Quarter and 2018 Year-End Financial Results and Hold Conference Call / Webcast
PR Newswire
03/26 12:32
Prometic secures additional USD $5 million (CAD $6.7 million) tranche from structured Alpha LP, an affiliate of Thomvest Asset Management Inc., under its existing credit facilities
PR Newswire
03/25 07:00
Prometic secures additional $10M
SA Breaking News
02/25 08:43
Prometic secures additional USD $10 million (CAD $13.2 million) tranche from Structured Alpha LP, an affiliate of Thomvest Asset Management Inc., under its existing credit facilities
PR Newswire
02/25 07:00
Prometic retains investment bank for strategic transactions
PR Newswire
02/14 07:00
National Bank upgrades ProMetic Life Sciences in premarket analyst action
SA Breaking News
01/28 07:51
Prof. Simon Best Appointed Interim CEO of Prometic Life Sciences
PR Newswire
12/19 07:30
Prometic to Initiate PBI-4050 Pivotal Phase 3 Clinical Trial in Alström Syndrome
PR Newswire
12/05 09:34
Prometic Provides Corporate Update
PR Newswire
11/28 07:00
ProMetic Life Sciences reports Q3 results
SA Breaking News
11/15 00:09
Prometic Reports Third Quarter 2018 Financial Results and Highlights
PR Newswire
11/14 20:39
Prometic Closes its Extension of Debt Maturities to 2024
PR Newswire
11/14 12:51
Prometic to Report its Third Quarter 2018 Financial Results and Hold Conference Call / Webcast
PR Newswire
11/12 17:34
Prometic Announces Extension of Debt Maturities to 2024
PR Newswire
10/29 07:00
Prometic announces second annual Plasminogen Deficiency Awareness Week
PR Newswire
10/25 15:37
Prometic announces positive feedback from FDA Type-C meeting on Typlazim BLA
SA Breaking News
10/16 08:15
Prometic announces positive feedback from FDA Type-C meeting on Ryplazim™ (plasminogen) BLA
PR Newswire
10/16 06:30
Prometic to host Key Opinion Leader meeting on PBI-4050, a novel treatment for Alström Syndrome and promising therapeutic for non alcoholic steatohepatitis (NASH)
PR Newswire
09/05 12:23
ProMetic Life Sciences reports Q2 results
SA Breaking News
08/14 18:10
Prometic Reports Second Quarter 2018 Financial Results and Highlights
PR Newswire
08/14 18:07
Prometic announces the publication of PBI-4050's antifibrotic activity in liver diseases in Journal of Pharmacology and Experimental Therapeutics
PR Newswire
08/10 07:15
Prometic to report its second quarter 2018 financial results and hold conference call / webcast
PR Newswire
08/07 14:21
Prometic receives Rare Pediatric Disease Designation from U.S. FDA for small molecule drug candidate, PBI-4050
PR Newswire
08/07 07:00
Prometic conference call to present progress report on AGM corporate action plan
PR Newswire
06/22 12:38
Prometic Presents New Data on NASH Drug Candidate PBI-4547
PR Newswire
06/22 07:00
Prometic presents new clinical data on PBI-4050 for the treatment of idiopathic pulmonary fibrosis
PR Newswire
05/22 13:31
ProMetic Life Sciences reports Q1 results
SA Breaking News
05/15 17:53
Prometic reports its 2018 first quarter highlights and financial results
PR Newswire
05/15 17:44
Prometic reports on its 2018 annual and special meeting of shareholders highlights
PR Newswire
05/10 17:13
Prometic Reports Positive Clinical Data from its Intravenous Immunoglobulin (IVIG) Pivotal Phase 3 Trial
PR Newswire
04/30 06:30
Prometic Presents New PBI-4050 Clinical Data From Ongoing Alström Syndrome Phase 2 Trial
PR Newswire
04/12 06:30
Prometic Announces Appointment of Bruce Wendel as Chief Business Development Officer
PR Newswire
04/03 07:00
ProMetic Life Sciences reports FY results
SA Breaking News
03/29 03:11
Prometic Reports Positive Clinical Data From Ongoing PBI-4050 Study in Alström Syndrome Patients
PR Newswire
03/28 21:26
Prometic Reports its Q4-2017 and YE-2017 Financial Results and Provides Update on Activities
PR Newswire
03/28 20:59
Prometic to report its Fourth Quarter and Year-End 2017 Financial Results and hold Conference Call / Webcast
PR Newswire
03/26 07:00
Prometic receives Rare Pediatric Disease Designation from U.S. FDA for its Inter-Alpha-Inhibitor-Proteins
PR Newswire
03/05 07:00